Longevity
|
phenotype |
|
Temporal Concept
|
48
|
74
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
CUI: |
C0030193 |
Disease: |
Pain
|
Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1554
|
196
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.400 |
moderate |
1.000 |
2 |
1
|
2017 |
2019 |
Hyperalgesia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
451
|
4
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Visual symptoms
|
phenotype |
|
Sign or Symptom
|
17
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mechanical Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
408
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2020 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2016 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Papilloma
|
disease |
Neoplasms
|
Neoplastic Process
|
273
|
27
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Thyroid Nodule
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
150
|
17
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Choroid Plexus Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1348
|
204
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Melanoma-Associated Retinopathy
|
disease |
Neoplasms; Eye Diseases
|
Neoplastic Process
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Squamous cell carcinoma of the head and neck
|
disease |
Neoplasms
|
Neoplastic Process
|
1543
|
348
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Tumor Promotion
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
170
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.400 |
moderate |
1.000 |
2 |
1
|
2017 |
2019 |
Autistic behavior
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
261
|
78
|
0.300 |
moderate |
1.000 |
2 |
|
2017 |
2019 |
Intellectual Disability
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
2165
|
159
|
0.310 |
moderate |
1.000 |
2 |
|
2017 |
2019 |
Amphetamine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
78
|
3
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amphetamine Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
2
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Amphetamine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
75
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |